Balance Sheets - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 27,280,309	$ 3,322,226
Accounts receivable, net	143,459	125,790
Inventory, net	150,336	131,378
Other current assets	759,453	284,115
Total current assets	28,333,557	3,863,509
Property and equipment, at cost:
Leasehold improvements	1,155,332	1,155,332
Office equipment	99,344	64,145
Furniture and fixtures	424,947	424,947
Machinery and equipment	2,262,908	2,242,088
Construction in progress	268,226	139,150
Property and equipment, Gross	4,210,757	4,025,662
Less accumulated depreciation	(2,600,787)	(2,197,868)
Net property and equipment	1,609,970	1,827,794
Long-term assets:
Lease right-of-use assets, net	759,018	1,057,506
Intangible assets, net of accumulated amortization	33,046	65,069
Other long-term assets	428,933	792,440
Total long-term assets	1,220,997	1,915,015
Total assets	31,164,524	7,606,318
Current liabilities:
Accounts payable	436,890	674,333
Accrued expenses	597,856	1,117,601
Clinical holdback - current portion	18,947	0
Notes payable - current portion	320,866	630,010
Lease liabilities - current portion	412,911	434,072
Other - current	32,895	32,895
Total current liabilities	1,820,365	2,888,911
Long-term liabilities:
Clinical holdback - long-term portion	155,960	164,972
Note payable - long-term portion	0	182,490
Lease liabilities - long-term portion	501,912	809,092
Other - long-term	32,895	32,895
Total long-term liabilities	690,767	1,189,449
Total liabilities	2,511,132	4,078,360
Commitments and contingencies
Stockholders' equity (deficit):
Common stock, $.001 par, 200,000,000 authorized, 11,916,943 shares issued and 11,799,720 outstanding as of September 30, 2021; and 95,583,558 authorized, 1,110,347 shares issued and 993,124 outstanding as of December 31, 2020	11,916	1,110
Treasury stock, 117,223 shares	(60,000)	(60,000)
Warrants	702,492	702,492
Additional paid-in-capital	108,374,466	22,725,949
Accumulated deficit	(80,375,482)	(75,202,490)
Total stockholders' equity (deficit)	28,653,392	(51,815,728)
Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)	31,164,524	7,606,318
Series B Preferred Stock [Member]
Redeemable convertible preferred stock:
Preferred stock	0	10,748,873
Series C Preferred Stock [Member]
Redeemable convertible preferred stock:
Preferred stock	0	44,594,813
Series A Preferred Stock [Member]
Stockholders' equity (deficit):
Preferred stock, Series A, $.001 par, none authorized, issued and outstanding as of September 30, 2021; 17,310,609 shares authorized, and 17,210,609 shares issued and outstanding as of December 31, 2020	$ 0	$ 17,211